|
REVIEW ARTICLE
Christian Müller
THE POTENTIAL OF CARDIAC MARKERS TO IMPROVE PATIENT MANAGEMENT……………………………………109
Birgit Herzig
IMPROVED CARDIAC PATIENT MANAGEMENT THROUGH CARDIAC MARKERS…………………………………….114
Manfred Theis
BONE MARKERS – THEIR NATURE AND CLINICAL USE …………………………………………………………………………117
Sanja Stanković, Nada Majkić-Singh
ADVANCES IN THE GENETIC BASIS OF ISCHEMIC STROKE ………………………………………………………………….123
Patrick J. Twomey
CERTAINTY IN AN UNCERTAIN WORLD
– A CLINICIANS’ VIEWPOINT OF SENSITIVITY AND PRECISION……………………………………………………………..135
Danica Popović, Mirko Popović
DILEMMAS AND CONTROVERSIES IN THE INTERPRETATION OF LABORATORY RESULTS…………………139
Ljubinka Gligić
STATUS OF DEVELOPMENT AND IMPLEMENTATION OF MEDICAL
LABORATORIES ACCREDITATION IN SERBIA…………………………………………………………………………………………..144
Mirjana Đerić, Sunčica Kojić-Damjanov, Velibor Čabarkapa, Nevena Eremić
BIOCHEMICAL MARKERS OF ATHEROSCLEROSIS…………………………………………………………………………………148
Vidosava B. Đorđević, Tatjana Ristić, Vladan ]osić,
Predrag Vlahović, Lilika Zvezdanović, Gordana Đorđević
INFLAMMATORY AND APOPTOTIC MARKERS IN ISCHEMIC HEART DISEASE PATIENTS ……………………..154
Jean-Sébastien Blanchet, Thomas Brinkmann
THE CLINICAL IMPACT OF WHO STANDARDIZATION OF PSA ASSAYS……………………………………………………161
XVI KONGRES MEDICINSKE BIOHEMIJE I LABORATORIJSKE MEDICINE
sa međunarodnim učešćem & 4th EFCC SYMPOSIUM FOR BALKAN REGION……………………………………….169
PLENARY SESSIONS171
POSTER SESSIONS……………………………………………………………………………………………………………………………………219
AUTHOR INDEX…………………………………………………………………………………………………………………………………………..321
OBAVEŠTENJA…………………………………………………………………………………………………………………………………………….324
Volume: 27 Belgrade, April – June 2008 Issue: 2
JMB 2008; 27 (2): 109–336 ©2008 by SMBS, Belgrade
|
